| # | Drug | Count |
|---|---|---|
| 0 | INSULIN GLARGINE | 78 |
| 1 | INSULIN LISPRO | 59 |
| 2 | ETRASIMOD | 52 |
| 3 | QUETIAPINE | 44 |
| 4 | METFORMIN | 42 |
| 5 | METFORMIN ER 500 MG | 36 |
| 6 | METFORMIN ER 750 MG | 36 |
| 7 | ADALIMUMAB | 35 |
| 8 | METHOTREXATE SODIUM | 32 |
| 9 | ETANERCEPT | 31 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ETRASIMOD | 52 | 0.0307 |
| 1 | THIOTHIXENE | 1 | 0.0046 |
| 2 | ZIPRASIDONE | 13 | 0.0036 |
| 3 | LEVOKETOCONAZOLE | 1 | 0.0013 |
| 4 | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE | 1 | 0.0013 |
| 5 | ECONAZOLE NITRATE | 1 | 0.0011 |
| 6 | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 1 | 0.0011 |
| 7 | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL | 1 | 0.0011 |
| 8 | HUMAN INSULIN | 7 | 0.0010 |
| 9 | ZIPRASIDONE MESYLATE | 13 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Insulin Analog [EPC] | 152 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 41 |
| 2 | Benzodiazepine [EPC] | 38 |
| 3 | Insulin [EPC] | 37 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 34 |
| 5 | GLP-1 Receptor Agonist [EPC] | 33 |
| 6 | Atypical Antipsychotic [EPC] | 31 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 31 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 30 |
| 9 | Antirheumatic Agent [EPC] | 29 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Cortisol Synthesis Inhibitor [EPC] | 1 | 0.0013 |
| 2 | Insulin [EPC] | 37 | 0.0008 |
| 3 | Insulin Analog [EPC] | 152 | 0.0003 |
| 4 | Provitamin D2 Compound [EPC] | 9 | 0.0003 |
| 5 | Antirheumatic Agent [EPC] | 29 | 0.0003 |
| 6 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |
| 7 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 22 | 0.0002 |
| 8 | Progestin Antagonist [EPC] | 1 | 0.0002 |
| 9 | Interleukin-6 Receptor Antagonist [EPC] | 27 | 0.0002 |